Cancer
Malignant Pancreatic Neoplasm
CI-CAN-00001159Explore in graph →
Top-level904 active trials8 approved drugs63 evidence items
- NCIt
- C9005
- ICD-10
- C25
- DOID
- 1793
- Other
- 1 more code
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00001159Explore in graph →
Clinical trials
3,630 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (516)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01383538 | FOLFIRINOX Plus IPI-926 for Advanced Pancreatic Adenocarcinoma | completed | Phase 1 | 15 | Andrew KoOTHER | 1 | Aug 8, 2017 | clinicaltrials |
| NCT01195415 | Vismodegib and Gemcitabine Hydrochloride in Treating Patients With Advanced Pancreatic Cancer | completed | Phase 2 | 25 | National Cancer Institute (NCI)NIH | 1 | Aug 7, 2017 | clinicaltrials |
| NCT01040000 |
| QUILT-3.019: Phase 2 Study of NPC-1C Chimeric Monoclonal Antibody to Treat Pancreatic and Colorectal Cancer |
| completed |
| Phase 1 / Phase 2 |
| 94 |
| Precision Biologics, IncINDUSTRY |
| 1 |
| Aug 4, 2017 |
| clinicaltrials |
| NCT01809028 | Evaluating the Number of Passes Required for Diagnostic Cell Block During EUS-FNA of Solid Pancreatic Mass Lesions | completed | N/A | 62 | AdventHealthOTHER | 1 | Aug 3, 2017 | clinicaltrials |
| NCT01815606 | Trial Comparing 19 and 25G Needles for Fine Needle Aspiration (FNA) of Solid Pancreatic Mass Lesions Greater Than 35mm | completed | N/A | 51 | AdventHealthOTHER | 1 | Aug 3, 2017 | clinicaltrials |
| NCT03236883 | Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation in the Treatment of Pancreatic Cancer(HST) | unknown | Phase 1 | 30 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Aug 2, 2017 | clinicaltrials |
| NCT01191684 | Vaccine Therapy in Treating Patients With Colorectal, Stomach, or Pancreatic Cancer | completed | Phase 1 | 12 | City of Hope Medical CenterOTHER | 1 | Aug 1, 2017 | clinicaltrials |
| NCT01303029 | Safety and Efficacy Study of Gemcitabine-erlotinib Versus Gemcitabine-erlotinib-capecitabine in Patients With Metastatic Pancreatic Cancer(GECA) | completed | Phase 2 | 120 | Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)OTHER | 1 | Aug 1, 2017 | clinicaltrials |
| NCT02080650 | Characterization of Circulating Tumor Cells Captured by c-MET (CTC-MET) | completed | N/A | 62 | Duke UniversityOTHER | 1 | Aug 1, 2017 | clinicaltrials |
| NCT02651727 | Ph 1 Study of VS-4718, a FAK Inhibitor, in Combination With Nab-paclitaxel and Gemcitabine in Advanced Cancer Subjects | terminated | Phase 1 | 13 | Verastem, Inc.INDUSTRY | 1 | Jul 27, 2017 | clinicaltrials |
| NCT03202199 | Neoadjuvant Chemotherapy Response Assessment by Combined PET-MRI in Borderline and Locally Advanced Pancreatic Adenocarcinoma.(PACMI) | unknown | N/A | 125 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Jul 26, 2017 | clinicaltrials |
| NCT00920023 | Pre-Operative Staging of Pancreatic Cancer Using Superparamagnetic Iron Oxide Magnetic Resonance Imaging (SPIO MRI) | completed | Phase 4 | 35 | Massachusetts General HospitalOTHER | 1 | Jul 25, 2017 | clinicaltrials |
| NCT02116322 | Endoscopic Ultrasound (EUS) Guided Fine Needle Aspiration (FNA) EUS-FNA of Solid Pancreatic Mass Lesions Using a Novel Corkscrew Technique: a Pilot Study | terminated | N/A | 4 | Johns Hopkins UniversityOTHER | 1 | Jul 24, 2017 | clinicaltrials |
| NCT02035072 | Phase II Study of Hypofractionated Radio-chemotherapy With Gemcitabine Plus Oxaliplatin for Unresectable Nonmetastatic Locally Advanced Pancreatic Cancer. | completed | Phase 2 | 40 | Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCSOTHER | 1 | Jul 21, 2017 | clinicaltrials |
| NCT01729481 | Gemcitabine Plus Erlotinib in RASH-positive Patients With Metastatic Pancreatic Cancer(ML22774) | unknown | Phase 2 | 150 | Ludwig-Maximilians - University of MunichOTHER | 1 | Jul 19, 2017 | clinicaltrials |
| NCT02108782 | Dovitinib Lactate in Treating Patients With Pancreatic Neuroendocrine Tumors | withdrawn | Phase 2 | 0 | Academic and Community Cancer Research UnitedOTHER | 0 | Jul 19, 2017 | clinicaltrials |
| NCT00609336 | Perioperative Therapy for Resectable Pancreatic Cancer | completed | Phase 2 | 35 | University of WashingtonOTHER | 1 | Jul 13, 2017 | clinicaltrials |
| NCT01016483 | Trial of Gemcitabine With or Without MSC1936369B in Pancreatic Cancer | completed | Phase 1 / Phase 2 | 141 | EMD SeronoINDUSTRY | 2 | Jul 13, 2017 | clinicaltrials |
| NCT01236053 | Cancer in Patients With Gabapentin (GPRD) | completed | — | 2,323,608 | GlaxoSmithKlineINDUSTRY | 0 | Jul 6, 2017 | clinicaltrials |
| NCT01209962 | A Pilot Study of Diffusion MRI in the Assessment of Pancreatic Tumor Response | completed | — | 20 | University of Michigan Rogel Cancer CenterOTHER | 1 | Jul 5, 2017 | clinicaltrials |
| NCT00987766 | Gemcitabine Hydrochloride, Oxaliplatin, and Erlotinib Hydrochloride in Treating Patients With Advanced Biliary Tract Cancer, Pancreatic Cancer, Duodenal Cancer, or Ampullary Cancer | completed | Phase 1 | 28 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Jul 2, 2017 | clinicaltrials |
| NCT01386502 | CT-011 and p53 Genetic Vaccine for Advanced Solid Tumors | withdrawn | Phase 1 | 0 | National Cancer Institute (NCI)NIH | 1 | Jul 2, 2017 | clinicaltrials |
| NCT02117258 | Z-360 Plus GEM in Subjects With Metastatic Pancreatic Adenocarcinoma(ZIPANG) | completed | Phase 2 | 167 | Zeria PharmaceuticalINDUSTRY | 3 | Jul 2, 2017 | clinicaltrials |
| NCT02465892 | Pillars4Life Trial(Pillars4Life) | completed | N/A | 284 | Duke UniversityOTHER | 1 | Jul 2, 2017 | clinicaltrials |
| NCT03200821 | An Open Label Study to Evaluate G17DT Compared to Gemcitabine | completed | Phase 3 | 103 | Cancer Advances Inc.INDUSTRY | 0 | Jun 27, 2017 | clinicaltrials |
| NCT01794676 | Genetic Evaluation of Families With Endocrine Cancers(MEN1) | completed | — | 9 | Jersey Shore University Medical CenterOTHER | 1 | Jun 16, 2017 | clinicaltrials |
| NCT01273805 | Hydroxychloroquine in Previously Treated Patients With Metastatic Pancreatic Cancer | completed | Phase 2 | 20 | Dana-Farber Cancer InstituteOTHER | 1 | Jun 14, 2017 | clinicaltrials |
| NCT01646697 | Slide Interpretation or Standard Surgical Pathology in Assessing Margin Status in Patients With Pancreatic Cancer Undergoing Surgery | completed | N/A | 90 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Jun 9, 2017 | clinicaltrials |
| NCT01515046 | Clinical Trial of High-dose Vitamin C for Advanced Pancreatic Cancer(PACMAN-II) | terminated | Phase 2 | 1 | Joseph J. CullenOTHER | 1 | Jun 8, 2017 | clinicaltrials |
| NCT03178812 | Role of the Cystic Fluid Interleukins and Tumor Necrosis Factor (TNF) Levels in Characterizing Pancreatic Cysts Detected by Endoscopic Ultrasound (EUS) | unknown | N/A | 30 | Hillel Yaffe Medical CenterOTHER_GOV | 1 | Jun 7, 2017 | clinicaltrials |
| NCT00424827 | A Trial of Chemo & Radiation Therapy for Pancreatic Cancer | completed | Phase 2 | 11 | University of Massachusetts, WorcesterOTHER | 0 | Jun 1, 2017 | clinicaltrials |
| NCT00376987 | Zinc Supplements in Lowering Cadmium Levels in Smokers | completed | Phase 2 | 61 | Wake Forest University Health SciencesOTHER | 1 | May 30, 2017 | clinicaltrials |
| NCT00489515 | Visceral Lymphatic Mapping Using Isosulfan Blue in Patients With Cancer of the Pancreas, Colon, Stomach, Small Intestine, or Gallbladder | completed | — | 115 | Wake Forest University Health SciencesOTHER | 1 | May 30, 2017 | clinicaltrials |
| NCT00534001 | Bupropion in Helping Adults Stop Smoking | completed | Phase 2 | 95 | Roswell Park Cancer InstituteOTHER | 1 | May 30, 2017 | clinicaltrials |
| NCT01138124 | Gabapentin and Risk of Pancreatic Cancer and Renal Cancer (GPRD) | completed | — | 54,202 | GlaxoSmithKlineINDUSTRY | 0 | May 30, 2017 | clinicaltrials |
| NCT03166436 | RFA for Malignant Biliary Obstruction | unknown | N/A | 140 | Institute for Clinical and Experimental MedicineOTHER_GOV | 1 | May 30, 2017 | clinicaltrials |
| NCT00654160 | Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer | completed | Phase 1 | 7 | Mayo ClinicOTHER | 1 | May 25, 2017 | clinicaltrials |
| NCT00836992 | Quality of Life in Patients Undergoing Radiation Therapy for Primary Lung Cancer, Head and Neck Cancer, or Gastrointestinal Cancer | completed | — | 144 | Mayo ClinicOTHER | 1 | May 24, 2017 | clinicaltrials |
| NCT00974610 | Study of Blood Samples From Patients With Malignant Melanoma, Metastatic Breast Cancer, Advanced Lung Cancer, Pancreatic Cancer, or Colorectal Cancer. | completed | — | 803 | Cancer Trials IrelandNETWORK | 1 | May 24, 2017 | clinicaltrials |
| NCT01303159 | Endoscopic Bipolar Radiofrequency Probe (ENDOHPB) in the Management of Unresectable Bile Duct and Pancreatic Cancer | terminated | N/A | 29 | Weill Medical College of Cornell UniversityOTHER | 1 | May 23, 2017 | clinicaltrials |
| NCT00841035 | 7 Day's of Erlotinib Neo-adjuvant, Followed by Adjuvant Erlotinib-gemcitabine in Pancreatic Cancer Patients | terminated | Phase 2 | 6 | University of Alabama at BirminghamOTHER | 1 | May 19, 2017 | clinicaltrials |
| NCT01940237 | A Pilot Trial of Interpersonal Psychotherapy for the Treatment of Depression in Patients With Prostate, Colorectal, Lung and Pancreatic Cancer | terminated | N/A | 4 | New York State Psychiatric InstituteOTHER | 1 | May 19, 2017 | clinicaltrials |
| NCT01608711 | A Study of AGS-1C4D4 in Pancreatic Cancer Subjects Previously Treated in Protocol 2008002 | completed | Phase 2 | 2 | Agensys, Inc.INDUSTRY | 2 | May 16, 2017 | clinicaltrials |
| NCT01844817 | Phase II Trial Of Gemcitabine Plus Nab-Paclitaxel +/- OGX-427 In Patients With Metastatic Pancreatic Cancer(Rainier) | completed | Phase 2 | 132 | SCRI Development Innovations, LLCOTHER | 1 | May 16, 2017 | clinicaltrials |
| NCT02243007 | Phase II Study of Preoperative FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel in Patients With Resectable Pancreatic Cancer | terminated | Phase 2 | 7 | Massachusetts General HospitalOTHER | 1 | May 16, 2017 | clinicaltrials |
| NCT00366457 | Gemcitabine, Bevacizumab and Erlotinib in Pancreatic Cancer | completed | Phase 2 | 32 | Massachusetts General HospitalOTHER | 1 | May 15, 2017 | clinicaltrials |
| NCT02202785 | A Study of MLN0264 in Patients With Pancreatic Cancer | terminated | Phase 2 | 43 | Millennium Pharmaceuticals, Inc.INDUSTRY | 4 | May 15, 2017 | clinicaltrials |
| NCT00691054 | Abraxane Therapy in Patients With Pancreatic Cancer Who Failed First-Line Gemcitabine Therapy | completed | Phase 2 | 20 | University of MiamiOTHER | 2 | May 11, 2017 | clinicaltrials |
| NCT00948688 | Vorinostat With XRT and 5-FU for Locally Advanced Adenocarcinoma of the Pancreas | terminated | Phase 1 / Phase 2 | 10 | Massachusetts General HospitalOTHER | 1 | May 10, 2017 | clinicaltrials |
| NCT00882973 | Trial to Determine the Maximum Tolerated Dose of Genexol-PM Plus Gemcitabine and Evaluate Efficacy and Safety of Genexol-PM Regimens in Subjects With Advanced Pancreatic Cancer | completed | Phase 1 | 18 | Samyang Biopharmaceuticals CorporationINDUSTRY | 0 | May 5, 2017 | clinicaltrials |
Data updated 24 days agoSource updated Aug 8, 2017source: clinicaltrials